Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The use of integrative therapies in patients with amyotrophic lateral sclerosis in shanghai, china.

Pan W, Chen X, Bao J, Bai Y, Lu H, Wang Q, Liu Y, Yuan C, Li W, Liu Z, Liu J, Zhu X, Qin B, Cai D, Zhou H.

Evid Based Complement Alternat Med. 2013;2013:613596. doi: 10.1155/2013/613596. Epub 2013 Dec 2.

PMID:
24363770
2.

The use of herbal supplements and alternative therapies by patients with amyotrophic lateral sclerosis (ALS).

Vardeny O, Bromberg MB.

J Herb Pharmacother. 2005;5(3):23-31.

PMID:
16520295
3.

High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.

Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, Becker G, Osterhage J, Jost WH, Schrank B, Stein C, Kostopulos P, Lubik S, Wekwerth K, Dengler R, Troeger M, Wuerz A, Hoge A, Schrader C, Schimke N, Krampfl K, Petri S, Zierz S, Eger K, Neudecker S, Traufeller K, Sievert M, Neundörfer B, Hecht M; German vitamin E/ALS Study Group..

J Neural Transm (Vienna). 2005 May;112(5):649-60. Epub 2004 Oct 27.

PMID:
15517433
4.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Review.

PMID:
13129806
5.

Age at onset of amyotrophic lateral sclerosis in China.

Liu MS, Cui LY, Fan DS; Chinese ALS Association..

Acta Neurol Scand. 2014 Mar;129(3):163-7. doi: 10.1111/ane.12157. Epub 2013 Jul 2.

PMID:
23819875
6.

Interdisciplinary palliative care, including massage, in treatment of amyotrophic lateral sclerosis.

Blatzheim K.

J Bodyw Mov Ther. 2009 Oct;13(4):328-35. doi: 10.1016/j.jbmt.2008.04.040. Epub 2008 Jul 10. Review.

PMID:
19761955
7.

Clinical features of amyotrophic lateral sclerosis in south-west China.

Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, Zhao B, Shang H.

Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):512-9. doi: 10.3109/21678421.2015.1069849. Epub 2015 Jul 23.

PMID:
26203659
8.
9.

Natural compounds used as therapies targeting to amyotrophic lateral sclerosis.

Nabavi SF, Daglia M, D'Antona G, Sobarzo-Sánchez E, Talas ZS, Nabavi SM.

Curr Pharm Biotechnol. 2015;16(3):211-8. Review.

PMID:
25601606
10.

Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M; Northeast and Canadian Amyotrophic Lateral Sclerosis consortia..

Lancet Neurol. 2010 May;9(5):481-8. doi: 10.1016/S1474-4422(10)70068-5. Epub 2010 Apr 1.

PMID:
20363190
11.

Exposing asymmetric gray matter vulnerability in amyotrophic lateral sclerosis.

Devine MS, Pannek K, Coulthard A, McCombe PA, Rose SE, Henderson RD.

Neuroimage Clin. 2015 Mar 14;7:782-7. doi: 10.1016/j.nicl.2015.03.006. eCollection 2015.

PMID:
25844330
12.

[What are the etiological medical therapies in amyotrophic lateral sclerosis?].

Dib M.

Rev Neurol (Paris). 2006 Jun;162 Spec No 2:4S215-4S219. French.

PMID:
17128114
13.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Cochrane Database Syst Rev. 2002;(2):CD001447. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD001447.

PMID:
12076411
14.

An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China.

Guo XY, Chen YP, Song W, Zhao B, Cao B, Wei QQ, Ou RW, Yang Y, Yuan LX, Shang HF.

Eur J Neurol. 2014 Oct;21(10):1337-43. doi: 10.1111/ene.12490. Epub 2014 Jul 12.

PMID:
25040112
15.

Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.

Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, Lepore V, Simone IL, Lamberti P, Serlenga L, Logroscino G; SLAP registry..

Eur J Neurol. 2007 Mar;14(3):262-8.

PMID:
17355545
16.

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Miller RG, Mitchell JD, Lyon M, Moore DH.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001447. Review. Update in: Cochrane Database Syst Rev. 2012;3:CD001447.

PMID:
17253460
17.

An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.

Traynor BJ, Alexander M, Corr B, Frost E, Hardiman O.

J Neurol. 2003 Apr;250(4):473-9.

PMID:
12700914
18.

Protocol for a double-blind randomised placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) [Eudract number: 2008-006891-31].

Al-Chalabi A, Shaw PJ, Young CA, Morrison KE, Murphy C, Thornhill M, Kelly J, Steen IN, Leigh PN; UKMND-LiCALS..

BMC Neurol. 2011 Sep 21;11:111. doi: 10.1186/1471-2377-11-111.

PMID:
21936930
19.

Association between depression and survival in Chinese amyotrophic lateral sclerosis patients.

Wei Q, Zheng Z, Guo X, Ou R, Chen X, Huang R, Yang J, Shang H.

Neurol Sci. 2016 Apr;37(4):557-63. doi: 10.1007/s10072-015-2472-y. Epub 2016 Jan 13.

PMID:
26758858
20.

Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012.

Nazemi M, Raad MH, Arzoomanian CS, Ghasemzadeh A.

Electron Physician. 2016 Mar 25;8(3):2194-8. doi: 10.19082/2194. eCollection 2016 Mar.

PMID:
27123230

Supplemental Content

Support Center